Despite the negative press and beating they have taken all appears they are beginning to deliver on the goals they set. Management is right on time, budget and target. Money from Zertane will aide the approval of Ampion, a remarkable drug from my research.
Good research will reward you. There is absolutely no stopping Ampio now. The shorts are going to get slaughtered very very soon and they don't even know it yet. This is the most amazing company, pipeline and management I have ever seen. This is truly going to be one of the greatest shows on Wall Street starting very soon.